Preferred Name | Isotretinoin | |
Synonyms |
Neovitamin A 13-cis retinoic acid Isotretinoinum 13-cis-Retinoic Acid 13-cis-Vitamin A Acid ISOTRETINOIN 3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)2-cis-4-trans-6-trans-8-trans-nonatetraenoic Acid Isotretinoin 13-cis-Retinoate cis-Retinoic Acid Retinoicacid-13-cis Neovitamin A Acid isotretinoin 13-cRA Absorica Accure Accutane Amnesteem Cistane Claravis Isotrex Isotrexin Myorisan Oratane Ro 4-3780 Ro-4-3780 Roaccutan Roaccutane Roacutan Sotret ZENATANE |
|
Definitions |
A naturally-occurring retinoic acid with potential antineoplastic activity. Isotretinoin binds to and activates nuclear retinoic acid receptors (RARs); activated RARs serve as transcription factors that promote cell differentiation and apoptosis. This agent also exhibits immunomodulatory and anti-inflammatory responses and inhibits ornithine decarboxylase, thereby decreasing polyamine synthesis and keratinization. |
|
ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C603 |
|
Accepted_Therapeutic_Use_For |
Severe recalcitrant nodular acne; psoriasis; cornification disorders; cutaneous T-cell lymphoma; juvenile metastatic neuroblastoma and leukemia |
|
ALT_DEFINITION |
A drug that is used in the treatment of acne and psoriasis and is being studied in cancer prevention. It is a type of retinoid. |
|
CAS_Registry |
4759-48-2 |
|
CHEBI_ID |
CHEBI:6067 |
|
Chemical_Formula |
C20H28O2 |
|
code |
C603 |
|
Concept_In_Subset |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C176424 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C157711 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C173381 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C157712 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C173383 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C116978 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C201600 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C116977 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C128784 |
|
Contributing_Source |
CTRP FDA GDC HemOnc |
|
DEFINITION |
A naturally-occurring retinoic acid with potential antineoplastic activity. Isotretinoin binds to and activates nuclear retinoic acid receptors (RARs); activated RARs serve as transcription factors that promote cell differentiation and apoptosis. This agent also exhibits immunomodulatory and anti-inflammatory responses and inhibits ornithine decarboxylase, thereby decreasing polyamine synthesis and keratinization. |
|
Display_Name |
Isotretinoin |
|
FDA_UNII_Code |
EH28UP18IF |
|
FULL_SYN |
Neovitamin A 13-cis retinoic acid Isotretinoinum 13-cis-Retinoic Acid 13-cis-Vitamin A Acid ISOTRETINOIN 3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)2-cis-4-trans-6-trans-8-trans-nonatetraenoic Acid Isotretinoin 13-cis-Retinoate cis-Retinoic Acid Retinoicacid-13-cis Neovitamin A Acid isotretinoin 13-cRA Absorica Accure Accutane Amnesteem Cistane Claravis Isotrex Isotrexin Myorisan Oratane Ro 4-3780 Ro-4-3780 Roaccutan Roaccutane Roacutan Sotret ZENATANE |
|
Has_Target | ||
Is_Value_For_GDC_Property | ||
label |
Isotretinoin |
|
Legacy Concept Name |
Isotretinoin |
|
Maps_To |
Isotretinoin |
|
NCI_Drug_Dictionary_ID |
42657 |
|
NSC Number |
329481 |
|
PDQ_Closed_Trial_Search_ID |
42657 |
|
PDQ_Open_Trial_Search_ID |
42657 |
|
Preferred_Name |
Isotretinoin |
|
prefixIRI |
Thesaurus:C603 |
|
Semantic_Type |
Organic Chemical Pharmacologic Substance |
|
UMLS_CUI |
C0022265 |
|
subClassOf |